Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical TrialLeticia Rosario Cruz, María Margarita López Vázquez, Ariadna García et al.|ACS Pharmacology & Translational Science|2020Cited by 45
Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia. A Randomized and Controlled Clinical TrialLeticia Rosario Cruz, Idania Baladrón, Aliusha Rittoles et al.|medRxiv|2020Cited by 5
Péptido inmunomodulador CIGB-258 para el tratamiento de pacientes graves y críticos con la COVID-19Rafael Venegas Rodríguez, María del Carmen Domínguez-Horta, Rubén Peña Ruiz et al.|Unknown|2020Cited by 1
El tratamiento con Jusvinza disminuye la hiperinflamación y la hipercoagulación en pacientes críticos con la COVID-19Rafael Venegas Rodríguez, María del Carmen Domínguez Horta, Anabel Serrano Díaz et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2021Cited by 1